GLP3-R
Price range: $199.00 through $449.00
RETATRUTIDE comes in 10 MG, 20 MG, 30 MG, 60 MG
- GLP3-R is currently in Phase 3 clinical trials, and is not yet approved for medical use.
- It is important to note that GLP3-R may not be suitable for everyone and should be discussed with a healthcare professional.
- GLP3-R should be used in conjunction with a healthy lifestyle, including a balanced diet and regular exercise, to maximize its benefits.
RETATRUTIDE
GLP3-R is a novel medication currently under investigation for the potential treatment of obesity and type 2 diabetes. It is a triple receptor agonist that activates the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors.
Benefits of GLP3-R:
• Potential significant weight loss: Clinical trials have shown that GLP3-R may potentially lead to substantial weight loss, with participants losing an average of 20-24% of their body weight over 48 weeks.
• Improved glycemic control: GLP3-R has been found to potentially improve blood sugar levels in individuals with type 2 diabetes, reducing the need for insulin or other anti-diabetic medications.
• Reduced cardiovascular risk: Studies suggest that GLP3-R may potentially reduce the risk of cardiovascular events, such as heart attack and stroke, by improving metabolic health.
• Improved liver function: GLP3-R has been shown to potentially reduce liver fat and improve liver function in individuals with obesity and non-alcoholic fatty liver disease.
